Page 3 - ஜேக் வாணிலண்திங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Odyssey Group International Announces Recent Television Segments on Fox Business, CheddarTV and Newsmax

Odyssey Group International Announces Recent Television Segments on Fox Business, CheddarTV and Newsmax
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

Michael redmondBrett favreKurt warnerJake vanlandinghamMark rypienNewsmax national report onPrevacus incCompany or odysseyOdyssey group international incOdyssey group internationalClosing bellNational reportKennedy nationMonday februaryFox newSaturday february

Prevacus Announces Sale of PRV-002 to Odyssey Group International

Prevacus Announces Sale of PRV-002 to Odyssey Group International TALLAHASSEE, FL / ACCESSWIRE / February 5, 2021 / Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and other neurological disorders; today announced that it has entered into a definitive agreement for the sale of drug candidate PRV-002 to Odyssey Group International (OTCQB:ODYY). A definitive agreement has been signed and the transaction is expected to close by the end of February 2021, the transaction is conditional on Prevacus shareholder approval and other customary closing conditions. Dr. Jake Vanlandingham, Prevacus Chief Executive Officer, will join Odyssey and continue to be instrumental in the development of PRV-002 focused on a treatment for concussion.

Michael redmondKostenloser wertpapierhandelJake vanlandinghamPrevacus incOdyssey group international incOdyssey group internationalPrevacus chief executive officerChief executive officer michael redmondGroup internationalPrivate securities litigation reform actInvestors contactsமைக்கேல் ரெட்மண்ட்ஜேக் வாணிலண்திங்கம்ஒடிஸி குழு சர்வதேச இன்க்ஒடிஸி குழு சர்வதேசதலைமை நிர்வாகி அதிகாரி மைக்கேல் ரெட்மண்ட்

Odyssey Group International, Inc : Odyssey Group International s Planned Acquisition of Concussion Drug from Prevacus, Inc Enhances Delivery Capabilities with Nasal Therapeutic

(1) Provides Safer and Faster Access to the Brain IRVINE, CA / ACCESSWIRE / January 26, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) (the Company or Odyssey ), a technology and asset acquisition company focused on developing unique, life-saving medical products, is pleased to announce it is circulating a video to better define its drug candidate PRV-002, a therapeutic compound drug to treat concussion (mild traumatic brain injury (mTBI), from Prevacus Inc. For an overview demonstration of the nasal therapeutic delivery, please view: https://www.youtube.com/watch?v=NaPY-WtjUCI. The fast acting 5-minute nasal therapeutic delivery works through gene amplification and crosses into the brain to reduce inflammation, oxidative stress and swelling at the contusion site. The resulting animal data reduces headaches, improves memory, prevents balance impairment and prevents life-threatening increases in brain pressure.

Kostenloser wertpapierhandelBrett favreJake vanlandinghamPrevacus incCompany or odysseyOdyssey group international incProvides saferFaster accessOdyssey group internationalPrevacus chief executive officerActive pharmaceutical ingredientsGroup internationalPrivate securities litigation reform actInvestors contactsப்ரெட் பாவிரேஜேக் வாணிலண்திங்கம்

Odyssey Group International s Planned Acquisition of Concussion Drug from Prevacus, Inc Enhances Delivery Capabilities with Nasal Therapeutic

Odyssey Group International s Planned Acquisition of Concussion Drug from Prevacus, Inc Enhances Delivery Capabilities with Nasal Therapeutic
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

Brett favreJake vanlandinghamPrevacus incCompany or odysseyOdyssey group international incProvides saferFaster accessOdyssey group internationalPrevacus chief executive officerActive pharmaceutical ingredientsGroup internationalPrivate securities litigation reform actInvestors contactsப்ரெட் பாவிரேஜேக் வாணிலண்திங்கம்நிறுவனம் அல்லது ஒடிஸி

Odyssey Group International to Acquire Concussion Drug Asset from Prevacus, Inc

Odyssey Group International to Acquire Concussion Drug Asset from Prevacus, Inc
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

Michael redmondBrett favreJake vanlandinghamPrevacus incCompany or odysseyOdyssey group international incAll stock transactionTrial siteOdyssey group internationalPrevacus chief executive officerChief executive officer michael redmondGroup internationalPrivate securities litigation reform actInvestors contactsமைக்கேல் ரெட்மண்ட்ப்ரெட் பாவிரே